New strategies in hematopoietic stem cell transplantation: G-CSF-mobilized unprocessed whole blood

Brazilian Journal of Medical and Biological Research

Volumn 31, Issue 1, 1998, Pages 49-53

  Drager A M ^a   Ossenkoppele, G J ^a   Jonkhoff, A R ^a   Schuurhuis, G J ^a   Huijgens, P C ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cytokines; G CSF; Hematopoietic stem cells; Lymphoma; Multiple myeloma; Transplantation

Indexed keywords

CHEMOKINE; GRANULOCYTE COLONY STIMULATING FACTOR;

BLOOD; BONE MARROW; DRUG THERAPY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; METHODOLOGY; PHYSIOLOGY; RADIOTHERAPY; REVIEW; STEM CELL MOBILIZATION;

BLOOD; BONE MARROW; CHEMOKINES; DRUG THERAPY; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; RADIOTHERAPY;

EID: 0031615225     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X1998000100006     Document Type: Article

References (28)

1. Dührsen U, Villeval JL, Boyd J, Kannourakis G, Morstyn G & Metcalf D (1988). Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood, 72: 2074-2081.
2. Dreger P, Haferlach T, Eckstein V, Jacobs S, Suttrop M, Löffler H, Müller-Ruchholz W & Schmitz N (1994). G-CSF mobilized peripheral blood progenitor cells for allogenic transplantation: safety, kinetics of mobilization, and composition of the graft. British Journal of Haematology, 87: 609-613.
3. Waller CF, Bertz H, Wenger MK, Fetscher S, Hardung M, Engelhardt M, Behringer D, Lange W, Mertelsmann R & Finke J (1996). Mobilization of peripheral blood progenitor cells for allogenic transplantation: efficacy and toxicity of a high-dose rhG-CSF regimen. Bone Marrow Transplantation, 18: 279-283.
4. Dreger P, Klöss M, Petersen B, Haferlach T, Löffler H, Loeffler M & Schmitz N (1995). Autologous progenitor cell transplantation: prior exposure to stem cells toxic drugs determines yield and engraftment of peripheral blood progenitor cells but not of bone marrow grafts. Blood, 86: 3970-3978.
5. Haas R, Möhle R, Fruhauf S, Goldschmidt H, Witt B, Flentje M, Wannenmacher M & Hunstein W (1994). Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood, 83: 3787-3794.
6. Tricot G, Jagannath S, Vesole D, Nelson J, Tindle S, Miller L, Cheson B, Crowley J & Barlogie B (1995). Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. Blood, 85: 558-596.
7. Schmitz N, Linch DC, Dreger P, Goldstone AH, Boogaerts MA, Ferrant A, Demuynck HM, Link H, Znader A, Barge A & Borkett K (1996). Randomised trial of filgrastim mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet, 347: 353-357.
8. Andrews RG, Briddell RA, Knitter GH, Opie T, Bronsden M, Myerson D, Appelbaum FR & McNiece IK (1994). In vivo synergy between recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in baboons: enhanced circulation of progenitor cells. Blood, 84: 800-810.
9. Yan XQ, Hartley C, McElroy P, Chang A, McCrea C & McNiece I (1995). Peripheral blood progenitor cells mobilized by recombinant human granulocyte colony-stimulating factor plus recombinant rat stem cell factor contain long-term engrafting cells capable of cellular proliferation for more than two years as shown by serial transplantation in mice. Blood, 85: 2303-2307.
10. Fibbe W (1995). Interleukin-8 induces rapid mobilization of hematopoietic stem cells with radioprotective capacity and long term myelolymphoid repopulating ability. Blood, 85: 2269-2275.
11. Nemunaitis J (1996). Cytokine-mobilized peripheral blood progenitor cells. Seminars in Oncology, 23: 9-14.
12. Richman CM, Weiner RS & Yankee RA (1976). Increase in circulating stem cells following chemotherapy in man. Blood, 47: 1031-1039.
13. Haas R & Murea S (1995). The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells. Cytokines and Molecular Therapy, 1: 249-270.
14. Ossenkoppele GJ, Jonkhoff AR, Huijgens PC, Nauta JJP, van der Hem KG, Dräger AM & Langenhuijsen MMAC (1994). Peripheral blood progenitors mobilised by G-CSF (filgrastim) and reinfused as unprocessed autologous whole blood shorten the pancytopenic period following high-dose melphalan in multiple myeloma. Bone Marrow Transplantation, 13: 37-41.
15. Ossenkoppele GJ, Schuurhuis GJ, Jonkhoff AR, Dräger AM, Westra G, Oberink JW, Legdeur MCJC, Kreuk AM de, Zweegman S & Huijgens PC (1996). G-CSF (filgrastim)-stimulated whole blood kept unprocessed at 4°C does support a BEAM-like regimen in bad-risk lymphoma. Bone Marrow Transplantation, 18: 427-431.
16. Ossenkoppele GJ, Schuurhuis GJ, Jonkhoff AR, van der Hem KG, Legdeur MCJC, Boot-Bakker A, Westra AH, Dräger AM & Huijgens PC (1996). High dose melphalan with re-infusion of unprocessed G-CSF primed whole blood is effective and non-toxic therapy in multiple myeloma. European Journal of Haematology, 32A: 2058-2063.
17. Molineux G, Pojda Z, Hampson IN, Lord BI & Dexter TM (1990). Transplantation potential of peripheral blood stem cells induced by granulocyte colony-stimulating factor. Blood, 76: 2153-2158.
18. Demuynck H, Pettengell R, De Campos E, Dexter TM & Testa NG (1992). The capacity of peripheral blood stem cells mobilised with chemotherapy plus G-CSF to repopulate irradiated marrow stroma in vitro is similar to that of bone marrow. European Journal of Cancer, 28: 381-386.
19. Uyl-Groot CA, Huijgens PC & Rutten FFH (1996). Colony-stimulating factors and peripheral blood progenitor cell transplantation. PharmacoEconomics, 10: 23-35.
20. Jestice HK, Scott AM, Ager S, Tolliday BH & Marcus RE (1994). Liquid storage of peripheral blood progenitor cells for transplantation . Bone Marrow Transplantation, 14: 991-994.
21. Pettengell R, Woll PJ, O'Connor DA, Dexter TM & Testa NG (1994). Viability of haemopoietic progenitors from whole blood, bone marrow and leukapheresis product: effects of storage media, temperature and time. Bone Marrow Transplantation, 14: 703-709.
22. Ager S, Mahendra P, Jestice HK, Scott M & Marcus RE (1995). The use of non-cryopreserved peripheral blood progenitor cells in autologous transplantation. Bone Marrow Transplantation, 16: 633-634.
23. Ruiz-Argüelles GJ, Ruiz-Argüelles A, Pérez-Romano B, Marín-López A, Larregina-Díez A & Apreza-Molina MG (1995). Filgrastim-mobilized peripheral-blood stem cells can be stored at 4 degrees and used in autografts to rescue high dose chemotherapy. American Journal of Hematology, 48: 100-103.
24. + progenitor cells from bone marrow and peripheral blood during G-CSF enhanced recovery. Experimental Hematology, 23: 1535-1542.
25. + cells predict a rapid platelet recovery after peripheral blood stem cell transplantation. Blood, 5: 3313-3319.
26. Turner ML, Mcllwaine K, Anthony RS & Parker AC (1995). Differential expression of cell adhesion molecules by human hematopoietic progenitor cells from bone marrow and mobilized adult peripheral blood. Stem Cells, 13: 311-316.
27. Yong KL & Linch DC (1992). Differential effects of granulocyte and granulocyte-macrophage colony-stimulating factor (G-and GM-CSF) on neutrophil adhesion in vitro and in vivo. European Journal of Haematology, 49: 251-259.
28. Yong KL (1996). Granulocyte colony-stimulating factor (G-CSF) increases neutrophil migration across vascular endothelium independent of an effect on adhesion: comparison with granulocyte-macrophage colony-stimulating factor (GM-CSF). British Journal of Haematology, 94: 40-47.